Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INTAGAM feasibility study of Enterosgel in childhood acute infectious diarrhoea
PACTR202302683128875Phase 2Recruiting
- Sponsor
- Enteromed
- Start
- Apr 2023
- Modality
- Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Enterosgel in acute diarrhea, sponsored by Enteromed. Primary endpoint: Duration of diarrhoea to last watery stool. Started Apr 2023; status: recruiting.
02
Drugs
Enterosgel
03
Conditions
acute diarrhea
Beyond the preview
Go deeper on PACTR202302683128875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202302683128875.